KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2026)

Hims & Hers Health's Current Deferred Revenue history spans 7 years, with the latest figure at $165.1 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 49.08% to $165.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $165.1 million, a 49.08% increase, with the full-year FY2025 number at $127.2 million, up 68.87% from a year prior.
  • Current Deferred Revenue hit $165.1 million in Q1 2026 for Hims & Hers Health, up from $127.2 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for HIMS hit a ceiling of $165.1 million in Q1 2026 and a floor of $1.1 million in Q1 2022.
  • Historically, Current Deferred Revenue has averaged $46.3 million across 5 years, with a median of $13.7 million in 2024.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 53.83% in 2022 and later skyrocketed 919.92% in 2024.
  • Tracing HIMS's Current Deferred Revenue over 5 years: stood at $1.5 million in 2022, then skyrocketed by 425.34% to $7.7 million in 2023, then soared by 873.75% to $75.3 million in 2024, then surged by 68.87% to $127.2 million in 2025, then rose by 29.86% to $165.1 million in 2026.
  • Business Quant data shows Current Deferred Revenue for HIMS at $165.1 million in Q1 2026, $127.2 million in Q4 2025, and $118.5 million in Q3 2025.